parp inhibitory velaparib trialled in brca1/2 breast cancer
Published 7 years ago • 57 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
4:19
treating brca breast cancer with parp inhibition
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:54
dr. dieras on combo of veliparib and chemotherapy in brca1/2-mutant breast cancer
-
4:10
the embraca trial for advanced breast cancer, a new parp inhibitor
-
1:10
managing metastatic breast cancer and beyond using parp inhibitors
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
2:59
parp inhibitors for metastatic breast cancer
-
6:19
chemosymposium 2011: parp treatment for brca mutated and triple negative breast cancer
-
1:41
parp inhibitors are a promising alternative to chemotherapy for patients with metastatic brca1 a...
-
3:04
advances in parp inhibitor use for metastatic breast cancer
-
6:21
parp inhibition in brca1/2 or hrd- ovarian cancer
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
3:26
different treatment strategies for brca positive breast cancer
-
3:56
parp inhibitors: activity in brca1 versus brca2 altered mcrpc
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
0:58
dr. litton on the embraca trial in advanced brca1/2 breast cancer